COO - Earnings announcements

SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Thursday, June 4, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at www.investor.coopercos.com About CooperCompanies CooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beauti

SAN RAMON, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2026. First quarter 2026 revenue of $1.024 billion, up 6%, or up 3% organically, from last year's first quarter.First quarter 2026 GAAP diluted earnings per share (EPS) of $0.66, up $0.14 or 27% from last year's first quarter.First quarter 2026 Non-GAAP diluted EPS of $1.10, up $0.18 or 20% from last year's first quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. "We're pleased to report a strong start to the fiscal year, highlighted by product launches,

SAN RAMON, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today it will report first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beautiful mo

SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full year ended October 31, 2025. Fourth quarter 2025 revenue of $1,065.2 million, up 5%, or up 3% organically. Fiscal year 2025 revenue of $4.1 billion, up 5%, or up 4% organically.Fourth quarter 2025 GAAP diluted earnings per share (EPS) of $0.43, down 27%. Fiscal 2025 GAAP diluted EPS of $1.87, down 4%.Fourth quarter 2025 non-GAAP diluted EPS of $1.15, up 11%. Fiscal 2025 non-GAAP diluted EPS of $4.13, up 12%. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. "We closed fis

SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 2700541. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience l

SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025. Revenue increased 6% year-over-year to $1,060.3 million. CooperVision (CVI) revenue up 6% to $718.4 million, and CooperSurgical (CSI) revenue up 4% to $341.9 million.GAAP diluted earnings per share (EPS) of $0.49, down $0.03 or 6% from last year's third quarter.Non-GAAP diluted EPS of $1.10, up $0.14 or 15% from last year's third quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, CooperCompanies' Presiden

SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 3665386. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beaut

SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025. Revenue increased 6% year-over-year to $1,002.3 million. CooperVision (CVI) revenue up 5% to $669.6 million, and CooperSurgical (CSI) revenue up 8% to $332.7 million.GAAP diluted earnings per share (EPS) of $0.44, consistent with last year's second quarter.Non-GAAP diluted EPS of $0.96, up $0.11 or 14% from last year's second quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, CooperCompanies' President and CEO said,

 SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1515103. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beautiful

SAN RAMON, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2025. Revenue increased 4% year-over-year to $964.7 million. CooperVision (CVI) revenue up 4% to $646.1 million, and CooperSurgical (CSI) revenue up 3% to $318.6 million.GAAP diluted earnings per share (EPS) of $0.52, up $0.11 from last year's first quarter.Non-GAAP diluted EPS of $0.92, up $0.07 from last year's first quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "We started the y

SAN RAMON, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today announced it will report first quarter 2025 financial results on Thursday, March 6, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7466264. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beautiful moments through its two business unit

SAN RAMON, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2024. Fourth quarter 2024 revenue of $1,018.4 million, up 10%, or up 7% organically. Fiscal year 2024 revenue of $3.9 billion, up 8%, or up 8% organically.Fourth quarter 2024 GAAP diluted earnings per share (EPS) of $0.58, up 38%. Fiscal 2024 GAAP diluted EPS of $1.96, up 33%.Fourth quarter 2024 non-GAAP diluted EPS of $1.04, up 19%. Fiscal 2024 non-GAAP diluted EPS of $3.69, up 15%. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting o

SAN RAMON, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today announced it will report fourth quarter and full year 2024 financial results on Thursday, December 5, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 2026064. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates thr

SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024. Revenue increased 8% year-over-year to $1,002.8 million. CooperVision (CVI) revenue up 7% to $675.6 million, and CooperSurgical (CSI) revenue up 9% to $327.2 million.GAAP diluted earnings per share (EPS) of $0.52, up $0.09 or 22% from last year's third quarter.Non-GAAP diluted EPS of $0.96, up $0.12 or 14% from last year's third quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "Our

SAN RAMON, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today announced it will report third quarter 2024 financial results on Wednesday, August 28, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7528310. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two busine

SAN RAMON, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2024. Revenue increased 7% year-over-year to $942.6 million. CooperVision (CVI) revenue up 8% to $635.9 million, and CooperSurgical (CSI) revenue up 6% to $306.7 million.GAAP diluted earnings per share (EPS) of $0.44, up $0.24 or 122% from last year's second quarter.Non-GAAP diluted EPS of $0.85, up $0.08 or 10% from last year's second quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White,

SAN RAMON, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1712676. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two

SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million.GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5% from last year's first quarter.Non-GAAP diluted EPS of $0.85, up $0.12 or 18% from last year's first quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "W

SAN RAMON, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5337119. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two b

SAN RAMON, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023. Fourth quarter 2023 revenue of $927.1 million, up 9%, and up 9% organically. Fiscal year 2023 revenue of $3.6 billion, up 9%, or up 10% organically.Fourth quarter 2023 GAAP diluted earnings per share (EPS) of $1.70, up 29%. Fiscal 2023 GAAP diluted EPS of $5.91, down 24%.Fourth quarter 2023 non-GAAP diluted EPS of $3.47, up 26%. Fiscal 2023 non-GAAP diluted EPS of $12.81, up 3%. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on t

SAN RAMON, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today announced it will report fourth quarter and full year 2023 financial results on Thursday, December 7, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 3206652. A simultaneous audio webcast can be accessed on CooperCompanies' investor relations website at http://investor.coopercos.com. A replay of the event will be available on the same webpage following its conclusion. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a

SAN RAMON, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal third quarter ended July 31, 2023. Revenue increased 10% year-over-year to $930.2 million. CooperVision (CVI) revenue up 11% to $630.2 million, and CooperSurgical (CSI) revenue up 8% to $300.0 million.GAAP diluted earnings per share (EPS) of $1.71, down $0.27 or 14% from last year's third quarter.Non-GAAP diluted EPS of $3.35, up $0.16 or 5% from last year's third quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "We're very pleased to report another strong qua

SAN RAMON, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced it will report third quarter 2023 financial results on Wednesday, August 30, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5988827. A simultaneous audio webcast can be accessed on CooperCompanies' investor relations website at http://investor.coopercos.com. A replay of the event will be available on the same webpage following its conclusion. About CooperCompaniesCooperCompanies ("Cooper") is a global medical dev

SAN RAMON, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal second quarter ended April 30, 2023. Revenue increased 6% year-over-year to $877.4 million. CooperVision (CVI) revenue up 6% to $589.3 million, and CooperSurgical (CSI) revenue up 4% to $288.1 million.GAAP diluted earnings per share (EPS) of $0.80, down $1.75 or 69% from last year's second quarter.Non-GAAP diluted EPS of $3.08, down $0.16 or 5% from last year's second quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "This was another strong quarter with Cooper

SAN RAMON, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced it will report second quarter 2023 financial results on Thursday, June 1, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7116518. A simultaneous audio webcast can be accessed on CooperCompanies' investor relations website at http://investor.coopercos.com. A replay of the event will be available on the same webpage following its conclusion. About CooperCompaniesCooperCompanies ("Cooper") is a global medical device

SAN RAMON, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal first quarter ended January 31, 2023. Revenue increased 9% year-over-year to $858.5 million. CooperVision (CVI) revenue up 4% to $581.3 million, and CooperSurgical (CSI) revenue up 23% to $277.2 million.GAAP diluted earnings per share (EPS) of $1.70, down $0.21 or 11% from last year's first quarter.Non-GAAP diluted EPS of $2.90, down $0.34 or 10% from last year's first quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "We started the year on a positive not

SAN RAMON, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced it will report first quarter 2023 financial results on Thursday, March 2, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1757767. A simultaneous audio webcast can be accessed on CooperCompanies' investor relations website at http://investor.coopercos.com and a replay will be available shortly after the call on the same website. About CooperCompaniesCooperCompanies ("Cooper") is a global medical device company publi

SAN RAMON, Calif., Dec. 08, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2022. Fourth quarter revenue increased 12% year-over-year to $848.1 million. Fiscal 2022 revenue increased 13% to $3,308.4 million.Fourth quarter GAAP diluted earnings per share (EPS) of $1.32, down 89 cents or 40% from last year's fourth quarter. Fiscal 2022 GAAP diluted EPS of $7.76, down 87% from fiscal 2021.Fourth quarter Non-GAAP diluted EPS of $2.75, down 53 cents or 16% from last year's fourth quarter. Fiscal 2022 non-GAAP diluted EPS of $12.42, down 6% from fiscal 2021. See "Reconciliation of Selected GAAP R

SAN RAMON, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced it will release fourth quarter and full year 2022 financial results on Thursday, December 8, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The live dial-in number for the call is 800-715-9871. The conference ID is 2291153. A simultaneous webcast of the call will be available through the "Investor Relations" section of the CooperCompanies website at http://investor.coopercos.com. A replay of the webcast will be available approximately two hours following the event. A recording of the c

SAN RAMON, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal third quarter ended July 31, 2022. Revenue increased 10% year-over-year to $843.4 million. CooperVision (CVI) revenue up 2% to $566.3 million, and CooperSurgical (CSI) revenue up 35% to $277.1 million.GAAP diluted earnings per share $1.98, down $10.39 from last year's third quarter.Non-GAAP diluted earnings per share $3.19, down $0.22 or 6% from last year's third quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "We delivered record revenues this quarter with C

SAN RAMON, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced it will release third quarter 2022 financial results on Wednesday, August 31, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. To participate in the call please follow this link to register and receive the dial-in information. A simultaneous webcast of the call will be available through the "Investor Relations" section of the CooperCompanies website at http://investor.coopercos.com. A replay of the webcast will be available approximately two hours following the event. About CooperCompani

SAN RAMON, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal second quarter ended April 30, 2022. Revenue increased 15% year-over-year to $829.8 million. CooperVision (CVI) revenue up 6% to $553.8 million, and CooperSurgical (CSI) revenue up 40% to $276.0 million.GAAP diluted earnings per share $2.55, up $0.19 from last year's second quarter.Non-GAAP diluted earnings per share $3.24, down $0.14 or 4% from last year's second quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "CooperVision and CooperSurgical both posted st

Product Revenue Increased 30% to $1.8 million; OVA1plus Volume Grew 28% to 4,819 Units New Ordering Physicians in the First Quarter Grew 47% to 603 Year Over Year Board and Leadership appointments announced Conference Call and Webcast scheduled for today, May 11th at 8:30 a.m. ET AUSTIN, Texas, May 11, 2022 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on gynecologic disease, today reported its financial results for the first quarter ended March 31, 2022. "We are pleased to announce our first quarter 2022 results. Strong commercial performance – especially the trend in new ordering physicians - should set

SAN RAMON, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its first quarter of fiscal year 2022, which ended January 31, 2022. Revenue increased 16% year-over-year to $787.2 million. CooperVision (CVI) revenue up 11% to $561.5 million, and CooperSurgical (CSI) revenue up 30% to $225.7 million.GAAP diluted earnings per share $1.91, from $42.31 in last year's first quarter due to a significant deferred tax benefit recorded in the prior year period.Non-GAAP diluted earnings per share $3.24, up $0.07 or 2% from last year's first quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the resu

Acquisition will enhance CooperSurgical's international fertility footprint and medical device portfolio SAN RAMON, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced it has signed a binding letter of intent to acquire Cook Medical's Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. Cooper will pay approximately $875 million comprised of $675 million at closing and $200 million paid in four $50 million annual installments. "This acquisition is an excellent strategic fit for CooperSurgical." said Al White, CooperCompanies President and CEO. "We're improving our i

SAN RAMON, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced it will release first quarter 2022 financial results on Thursday, March 3, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is "Cooper". A simultaneous webcast of the call will be available through the "Investor Relations" section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a m

SAN RAMON, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2021. Fourth quarter revenue increased 11% year-over-year to $759.1 million. Fiscal 2021 revenue increased 20% to $2,922.5 million.Fourth quarter GAAP diluted earnings per share (EPS) $2.21, up 57 cents or 35% from last year's fourth quarter. Fiscal 2021 GAAP diluted EPS $59.16, up 1,131% from fiscal 2020.Fourth quarter Non-GAAP diluted EPS $3.28, up 12 cents or 4% from last year's fourth quarter. Fiscal 2021 non-GAAP diluted EPS $13.24, up 37% from fiscal 2020. See "Reconciliation of Selected GAAP Results to Non-G

SAN RAMON, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO), today announced it will release fourth quarter and full year 2021 financial results on Thursday, December 2, 2021, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is "Cooper". A simultaneous webcast of the call will be available through the "Investor Relations" section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on

SAN RAMON, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced financial results for its fiscal third quarter ended July 31, 2021. Revenue increased 32% year-over-year to $763.4 million. CooperVision (CVI) revenue up 24% to $557.5 million, and CooperSurgical (CSI) revenue up 60% to $205.9 million.GAAP diluted earnings per share $12.37, up $11.25 from last year's third quarter.Non-GAAP diluted earnings per share $3.41, up $1.13 or 50% from last year's third quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, Cooper's President and CEO said, "I am pleased to report another strong quarter wi

SAN RAMON, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO), today announced it will release third quarter 2021 financial results on Thursday, September 2, 2021, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is "Cooper". A simultaneous webcast of the call will be available through the "Investor Relations" section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for